C07D 207/08
With hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
Official title: with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
C07D207/08 (With hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms) appears on 1,696 US grants and 1,609 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,696
- Published applications
- 1,609
- Assignees
- 828
- Inventors
- 5,177
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 10 | 0 |
| 1978 | 12 | 0 |
| 1979 | 10 | 0 |
| 1980 | 15 | 0 |
| 1981 | 12 | 0 |
| 1982 | 12 | 0 |
| 1983 | 6 | 0 |
| 1984 | 11 | 0 |
| 1985 | 13 | 0 |
| 1986 | 15 | 0 |
| 1987 | 17 | 0 |
| 1988 | 19 | 0 |
| 1989 | 21 | 0 |
| 1990 | 24 | 0 |
| 1991 | 20 | 0 |
| 1992 | 36 | 0 |
| 1993 | 29 | 0 |
| 1994 | 29 | 0 |
| 1995 | 26 | 0 |
| 1996 | 62 | 0 |
| 1997 | 64 | 0 |
| 1998 | 42 | 0 |
| 1999 | 38 | 0 |
| 2000 | 19 | 0 |
| 2001 | 31 | 10 |
| 2002 | 31 | 34 |
| 2003 | 29 | 51 |
| 2004 | 33 | 76 |
| 2005 | 33 | 66 |
| 2006 | 38 | 63 |
| 2007 | 38 | 70 |
| 2008 | 40 | 65 |
| 2009 | 41 | 74 |
| 2010 | 49 | 75 |
| 2011 | 52 | 68 |
| 2012 | 50 | 67 |
| 2013 | 62 | 69 |
| 2014 | 67 | 69 |
| 2015 | 47 | 68 |
| 2016 | 60 | 73 |
| 2017 | 55 | 65 |
| 2018 | 51 | 59 |
| 2019 | 51 | 58 |
| 2020 | 37 | 71 |
| 2021 | 52 | 59 |
| 2022 | 45 | 71 |
| 2023 | 38 | 68 |
| 2024 | 37 | 59 |
| 2025 | 32 | 56 |
| 2026 | 25 | 45 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Ionizable cationic lipid analog material and use thereof as drug delivery carrier29 Sep 2026US 12,746,288 B2Guangzhou Lide Biomedicine Technology Co., Ltd.
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- N-heteroarylalkyl-2-(heterocyclyl and heterocyclylmethyl) acetamide derivatives as SSTR4 agonists22 Sep 2026US 12,741,957 B2Takeda Pharmaceutical Company Limited
- Methods and compositions for targeting Tregs using CCR8 inhibitors28 Jul 2026US 12,692,239 B2Nanjing Immunophage Biomedical Co., Ltd.
- Method of inhibiting tau phosphorylation7 Jul 2026US 12,674,134 B2Filana Therapeutics, Inc.
- Crystal form of lipoprotein compound and preparation method therefor8 Oct 2026US 2026/0306449 A1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives17 Sep 2026US 2026/0273017 A1Ambrx, Inc.
- Preparation method for intermediate of auristatin derivative17 Sep 2026US 2026/0274793 A1Remegen Co., Ltd.
- Novel co-drug, co-administration, and sequential administration of bispecific rbp4/ttr ligand and c20-d3-retinol for elimination of mechanism-based ocular adverse effects in treating macular degeneration and ttr amyloidosis3 Sep 2026US 2026/0256818 A1Rensselaer Polytechnic Institute
- Deubiquitinase inhibitors and methods of use thereof3 Sep 2026US 2026/0258011 A1
Most cited
By later US patents
- Cyclic amine compounds with activity against acetylcholinesterase174US 4,895,841 AEisai Co., Ltd. · 1990
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Muscarinic receptor antagonists138US 6,693,202 B1Theravance, Inc. · 2004
- Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics115US 5,364,866 AHoechst-Roussel Pharmaceuticals Inc. · 1994
- Inhibitors of DP-mediated processes, compositions and therapeutic methods thereof114US 5,939,560 AFerring B. V. · 1999